FreeIn the Archives Changing the paradigm: How a veterinary oncologist informed knowledge of hypoxia April 22, 2022Vol.48 No.16
Conversation with The Cancer Letter At ODAC without sponsors, FDA highlights safety signals in PI3K inhibitor trials April 15, 2022Vol.48 No.15By Paul Goldberg
In new complaint, DOJ says Memphis Methodist, West Clinic broke anti-kickback, false claims laws April 15, 2022Vol.48 No.15By Paul Goldberg
Conversation with The Cancer LetterFree Yuliya Nogovitsyna: Evacuating children with cancer from Ukraine “a risky operation” as drivers, suppliers are targeted April 15, 2022Vol.48 No.15By Alice Tracey
Conversation with The Cancer LetterFree ECO’s Mike Morrissey: Ukraine is a priority of our lifetime in oncology April 15, 2022Vol.48 No.15By Matthew Bin Han Ong
FreeIn the Archives Cancer disruptors: Jerome Yates on optimism and the ALGB April 15, 2022Vol.48 No.15
FreeTrials & Tribulations Let’s close this safety loophole in cancer care April 15, 2022Vol.48 No.15By Daniel E. Fass, Stuart P. Feldman and Mary Farrell Ajango
Conversation with The Cancer LetterFree Ned Sharpless steps down as NCI director April 08, 2022Vol.48 No.14By Matthew Bin Han Ong and Paul Goldberg
Conversation with The Cancer LetterFree Ukraine NCI’s Oleksandr Stakhovskyi: Cancer patients are returning to Kyiv April 08, 2022Vol.48 No.14By Alice Tracey
Obituary Barrie Cassileth, pioneer of integrative oncology, dies at 83 April 08, 2022Vol.48 No.14By Paul Goldberg
